Inhibition of the jun N-terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3

被引:54
作者
Robson, JD
Davidson, D
Veillette, A
机构
[1] Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada
[2] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3G 1Y6, Canada
[4] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada
[5] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada
关键词
D O I
10.1128/MCB.24.6.2332-2343.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dok-3 is a Dok-related adaptor expressed in B cells and macrophages. Previously, we reported that Dok-3 is an inhibitor of B-cell activation in A20 B cells and that it associates with SHIP-1, a 5' inositol-specific lipid phosphatase, as well as Csk a negative regulator of Src kinases. Here, we demonstrate that Dok-3 suppresses B-cell activation by way of its interaction with SHIP-1, rather than Csk. Our biochemical analyses showed that the Dok-3-SHIP-1 complex acts by selectively inhibiting the B-cell receptor (BCR)-evoked activation of the Jun N-terminal protein kinase (JNK) cascade without affecting overall protein tyrosine phosphorylation or activation of previously described SHIP-1 targets like Btk and Akt/PKB. Studies of B cells derived from SHIP-1-deficient mice showed that BCR-triggered activation of JNK is enhanced in the absence of SHIP-1, implying that the Dok-3-SHIP-1 complex (or a related mechanism) is a physiological negative regulator of the JNK cascade in normal B cells. Together, these data elucidate the mechanism by which Dok-3 inhibits B-cell activation. Furthermore, they provide evidence that SHIP-1 can be a negative regulator of JNK signaling in B cells.
引用
收藏
页码:2332 / 2343
页数:12
相关论文
共 46 条
  • [41] The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells
    Tamir, I
    Stolpa, JC
    Helgason, CD
    Nakamura, K
    Bruhns, P
    Daeron, M
    Cambier, JC
    [J]. IMMUNITY, 2000, 12 (03) : 347 - 358
  • [42] Tsai EY, 1996, MOL CELL BIOL, V16, P5232
  • [43] A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo
    Tsai, EY
    Falvo, JV
    Tsytsykova, AV
    Barczak, AK
    Reimold, AM
    Glimcher, LH
    Fenton, MJ
    Gordon, DC
    Dunn, IF
    Goldfeld, AE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (16) : 6084 - 6094
  • [44] THE CD4 AND CD8 T-CELL SURFACE-ANTIGENS ARE ASSOCIATED WITH THE INTERNAL MEMBRANE TYROSINE-PROTEIN KINASE P56LCK
    VEILLETTE, A
    BOOKMAN, MA
    HORAK, EM
    BOLEN, JB
    [J]. CELL, 1988, 55 (02) : 301 - 308
  • [45] Negative regulation of immunoreceptor signaling
    Veillette, A
    Latour, S
    Davidson, D
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 : 669 - 707
  • [46] Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2
    Yang, DD
    Conze, D
    Whitmarsh, AJ
    Barrett, T
    Davis, RJ
    Rincón, M
    Flavell, RA
    [J]. IMMUNITY, 1998, 9 (04) : 575 - 585